These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25544686)

  • 61. Predicting the mechanism of phospholipidosis.
    Lowe R; Mussa HY; Nigsch F; Glen RC; Mitchell JB
    J Cheminform; 2012 Jan; 4():2. PubMed ID: 22281160
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Improved toxicogenomic screening for drug-induced phospholipidosis using a multiplexed quantitative gene expression ArrayPlate assay.
    Sawada H; Taniguchi K; Takami K
    Toxicol In Vitro; 2006 Dec; 20(8):1506-13. PubMed ID: 16919414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Determination of the cationic amphiphilic drug-DNA binding mode and DNA-assisted fluorescence resonance energy transfer amplification.
    Yaseen Z; Banday AR; Hussain MA; Tabish M; Kabir-ud-Din
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():553-64. PubMed ID: 24334019
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Degradative transport of cationic amphiphilic drugs across phospholipid bilayers.
    Baciu M; Sebai SC; Ces O; Mulet X; Clarke JA; Shearman GC; Law RV; Templer RH; Plisson C; Parker CA; Gee A
    Philos Trans A Math Phys Eng Sci; 2006 Oct; 364(1847):2597-614. PubMed ID: 16973478
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Maintenance of luminal pH and protease activity in lysosomes/late endosomes by vacuolar ATPase in chlorpromazine-treated RAW264 cells accumulating phospholipids.
    Hamaguchi R; Haginaka J; Tanimoto T; Kuroda Y
    Cell Biol Toxicol; 2014 Feb; 30(1):67-77. PubMed ID: 24481857
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predicting phospholipidosis: a fluorescence noncell based in vitro assay for the determination of drug-phospholipid complex formation in early drug discovery.
    Zhou L; Geraci G; Hess S; Yang L; Wang J; Argikar U
    Anal Chem; 2011 Sep; 83(18):6980-7. PubMed ID: 21790130
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration.
    Yudate HT; Kai T; Aoki M; Minowa Y; Yamada T; Kimura T; Ono A; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2012 May; 295(1-3):1-7. PubMed ID: 22426296
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changes of phospholipase D activity of rat peritoneal mast cells in degranulation.
    Lu YB; Wu M; Zhou HL
    Acta Pharmacol Sin; 2004 Jan; 25(1):104-9. PubMed ID: 14704130
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence.
    Vonderfecht SL; Stone ML; Eversole RR; Yancey MF; Schuette MR; Duncan BA; Ware JA
    Toxicol Pathol; 2004; 32(3):318-25. PubMed ID: 15204973
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Substrate selectivities and lipid modulation of plant phospholipase D alpha, -beta, and -gamma.
    Pappan K; Austin-Brown S; Chapman KD; Wang X
    Arch Biochem Biophys; 1998 May; 353(1):131-40. PubMed ID: 9578608
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99.
    Lemieux B; Percival MD; Falgueyret JP
    Anal Biochem; 2004 Apr; 327(2):247-51. PubMed ID: 15051542
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of overexpression of glycosylphosphatidylinositol-specific phospholipase D on biological character of hepatocellular carcinoma cell line HepG2].
    He WJ; Tang JH; Tan CC; Duan Q; Wang KJ; Zuo KQ; Yuan XY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):103-9. PubMed ID: 18326903
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP.
    Mesens N; Desmidt M; Verheyen GR; Starckx S; Damsch S; De Vries R; Verhemeldonck M; Van Gompel J; Lampo A; Lammens L
    Toxicol Pathol; 2012 Apr; 40(3):491-503. PubMed ID: 22291062
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Amphiphilic cationic β(3R3)-peptides: membrane active peptidomimetics and their potential as antimicrobial agents.
    Mosca S; Keller J; Azzouz N; Wagner S; Titz A; Seeberger PH; Brezesinski G; Hartmann L
    Biomacromolecules; 2014 May; 15(5):1687-95. PubMed ID: 24694059
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
    Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W
    Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Putative biomarker for phospholipid accumulation in cultured cells treated with phospholipidosis-inducing drugs: alteration of the phosphatidylinositol composition detected using high-performance liquid chromatography-tandem mass spectrometry.
    Hamaguchi R; Tanimoto T; Kuroda Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 967():110-7. PubMed ID: 25086420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
    Bauch C; Bevan S; Woodhouse H; Dilworth C; Walker P
    Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment.
    Bocchini N; Giantin M; Crivellente F; Ferraresso S; Faustinelli I; Dacasto M; Cristofori P
    J Appl Toxicol; 2015 Jan; 35(1):90-103. PubMed ID: 25580480
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phospholipidosis effect of drugs by adsorption into lipid monolayers.
    Ceccarelli M; Germani R; Massari S; Petit C; Nurisso A; Wolfender JL; Goracci L
    Colloids Surf B Biointerfaces; 2015 Dec; 136():175-84. PubMed ID: 26387069
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A role for the autophagy regulator Transcription Factor EB in amiodarone-induced phospholipidosis.
    Buratta S; Urbanelli L; Ferrara G; Sagini K; Goracci L; Emiliani C
    Biochem Pharmacol; 2015 Jun; 95(3):201-9. PubMed ID: 25881747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.